14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ADAP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Adaptimmune Therapeutics plc stock price on Tuesday moving between $1.01 and $1.16
(Updated on Apr 23, 2024)

Sell candidate since Apr 02, 2024 Loss -18.57% PDF

The Adaptimmune Therapeutics plc stock price gained 12.87% on the last trading day (Tuesday, 23rd Apr 2024), rising from $1.01 to $1.14. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 15.42% from a day low at $1.01 to a day high of $1.16. The price has fallen in 6 of the last 10 days and is down by -16.79% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 437 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.29 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.38% during the next 3 months and, with a 90% probability hold a price between $1.01 and $2.05 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ADAP Signals & Forecast

There are mixed signals in the stock today. The Adaptimmune Therapeutics plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.37. On a fall, the stock will find some support from the short-term average at $1.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -34.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Adaptimmune Therapeutics plc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Adaptimmune Therapeutics plc stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.00 and $0.96. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adaptimmune Therapeutics plc finds support just below today's level at $1.00. If this is broken, then the next support from accumulated volume will be at $0.96 and $0.87.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.155 between high and low, or 15.42%. For the last week, the stock has had daily average volatility of 14.39%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADAP) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Adaptimmune Therapeutics plc to open at $1.10, and during the day (based on 14 day Average True Range), to move between $1.00 and $1.28, which gives a possible trading interval of +/-$0.140 (+/-12.26%) up or down from last closing price. If Adaptimmune Therapeutics plc takes out the full calculated possible swing range there will be an estimated 24.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.17 (2.63%) than the support at $1.00 (12.28%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Adaptimmune Therapeutics plc stock A Buy?

Adaptimmune Therapeutics plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.427 Sell Candidate Unchanged

Predicted Opening Price for Adaptimmune Therapeutics plc of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$1.10 ( 3.36%) $1.14

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ADAP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.26 10.23 %
R2 1.20 5.04 %
R1 1.16 1.83 %
Current price: 1.14
Support S1 1.04 -8.56 %
S2 1.01 -11.77 %
S3 0.95 -16.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.38 21.05 %
R2 1.33 16.67 %
R1 1.17 2.63 %
Current price 1.14
Support S1 1.00 -12.28%
S2 0.96 -15.79%
S3 0.87 -23.26%

FAQ

What is the symbol for Adaptimmune Therapeutics plc Stock and on which exchange is it traded?
The symbol for Adaptimmune Therapeutics plc is ADAP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Adaptimmune Therapeutics plc Stock?
Adaptimmune Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Adaptimmune Therapeutics plc Stock.

What's the current price of Adaptimmune Therapeutics plc Stock?
As of the end of day on the Apr 23, 2024, the price of an Adaptimmune Therapeutics plc (ADAP) share was $1.14.

What is the 52-week high and low for Adaptimmune Therapeutics plc Stock?
The 52-week high for Adaptimmune Therapeutics plc Stock is $2.05 and the 52-week low is $0.420.

What is the market capitalization of Adaptimmune Therapeutics plc Stock?
As of the Apr 23, 2024, the market capitalization of Adaptimmune Therapeutics plc is 250.433M.

When is the next earnings date for Adaptimmune Therapeutics plc?
The upcoming earnings date for Adaptimmune Therapeutics plc is May 10, 2024.
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT